About Horizon Discovery
Horizon Discovery is a company based in Cambridge (United Kingdom) founded in 2007 by Alberto Bardelli was acquired by PerkinElmer in November 2020.. Horizon Discovery has raised $46.29 million across 8 funding rounds from investors including PerkinElmer, Calculus Capital and University of Cambridge. Horizon Discovery has completed 2 acquisitions, including Dharmacon and Sage Research Labs. Horizon Discovery offers products and services including Pin-point™ Base Editing Reagents, CRISPR Guide RNA, siRNA, Custom Oligonucleotides, and Engineered Cell Lines. Horizon Discovery operates in a competitive market with competitors including Quanterix, Arrakis Therapeutics, NanoString, Souzhou Ribo Life Science and LGC, among others.
- Headquarter Cambridge, United Kingdom
- Founders Alberto Bardelli
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Horizon Discovery Group Limited
- Date of Incorporation 04 Mar, 2014
- Jurisdiction CAMBRIDGE, ENGLAND
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$46.29 M (USD)
in 8 rounds
-
Latest Funding Round
-
Investors
PerkinElmer
& 14 more
-
Employee Count
Employee Count
-
Investments & Acquisitions
Dharmacon
& 1 more
-
Acquired by
PerkinElmer
(Nov 02, 2020)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Horizon Discovery
Horizon Discovery offers a comprehensive portfolio of products and services, including Pin-point™ Base Editing Reagents, CRISPR Guide RNA, siRNA, Custom Oligonucleotides, and Engineered Cell Lines. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Reagents for next-generation gene editing applications
Guides for CRISPR-Cas9 experiments in research
Small interfering RNA for RNA interference studies
Tailored DNA and RNA for specific research needs
Pre-engineered cells for functional genomics testing
Unlock access to complete
Unlock access to complete
Funding Insights of Horizon Discovery
Horizon Discovery has successfully raised a total of $46.29M across 8 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 8
- Last Round Last Round
-
First Round
First Round
(07 Apr 2008)
- Investors Count 14
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2018 | Amount | Post-IPO - Horizon Discovery | Valuation |
investors |
|
| Aug, 2017 | Amount | Post-IPO - Horizon Discovery | Valuation |
investors |
|
| Jun, 2013 | Amount | Series C - Horizon Discovery | Valuation | Jonathan Milner |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Horizon Discovery
Horizon Discovery has secured backing from 15 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include PerkinElmer, Calculus Capital and University of Cambridge. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity investment firm based out of USA
|
Founded Year | Domain | Location | |
|
Venture capital firm investing in seed & early-stage startups
|
Founded Year | Domain | Location | |
|
Stage agnostic VC firm investing globally
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Horizon Discovery
Horizon Discovery has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Dharmacon and Sage Research Labs. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Animal research models are developed and provided for scientific use.
|
2009 | ||||
|
RNA oligonucleotide synthesis technology is provided for research applications.
|
1995 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Horizon Discovery
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Horizon Discovery Comparisons
Competitors of Horizon Discovery
Horizon Discovery operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Quanterix, Arrakis Therapeutics, NanoString, Souzhou Ribo Life Science and LGC, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Assay kits for ultra-sensitive biomarker detection are developed.
|
|
| domain | founded_year | HQ Location |
Provider of tools for the analysis of RNA structures
|
|
| domain | founded_year | HQ Location |
Tools for translational research and molecular diagnosis are developed.
|
|
| domain | founded_year | HQ Location |
Nucleic acid drugs are developed via RNA interference technology.
|
|
| domain | founded_year | HQ Location |
Molecular biology reagents and services are supplied to biotech industries.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Horizon Discovery
Frequently Asked Questions about Horizon Discovery
When was Horizon Discovery founded?
Horizon Discovery was founded in 2007 and raised its 1st funding round 1 year after it was founded.
Where is Horizon Discovery located?
Horizon Discovery is headquartered in Cambridge, United Kingdom. It is registered at Cambridge, Cambridgeshire, United Kingdom.
Who is the current CEO of Horizon Discovery?
Terry Pizzie is the current CEO of Horizon Discovery.
Is Horizon Discovery a funded company?
Horizon Discovery is a funded company, having raised a total of $46.29M across 8 funding rounds to date. The company's 1st funding round was a Series C of $10.5M, raised on Apr 07, 2008.
What does Horizon Discovery do?
Developer of cell lines with genetic modification using AAV gene-editing platform. The company has cell line engineering, knockout cell lines, and reporter cell lines. It also provides services in T cell activation assay, lymphocyte reaction assay, T cell-mediated tumor cell lysis assay, ADCC, and CDC assays, gene-editing for immuno-oncology, CRISPR Screening, drug combination screening, in vitro assay, and in-vivo assay.
Who are the top competitors of Horizon Discovery?
Horizon Discovery's top competitors include NanoString, Quanterix and Arrakis Therapeutics.
What products or services does Horizon Discovery offer?
Horizon Discovery offers Pin-point™ Base Editing Reagents, CRISPR Guide RNA, siRNA, Custom Oligonucleotides, and Engineered Cell Lines.
How many acquisitions has Horizon Discovery made?
Horizon Discovery has made 2 acquisitions, including Dharmacon, and Sage Research Labs.
Who are Horizon Discovery's investors?
Horizon Discovery has 15 investors. Key investors include PerkinElmer, Calculus Capital, University of Cambridge, MVM Partners, and Draper Esprit.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.